Pure Global

Cimosir Rivaroxaban correction liquid and quality control liquid - Taiwan Registration 9d34049d7c583ccd426393b116c0da47

Access comprehensive regulatory information for Cimosir Rivaroxaban correction liquid and quality control liquid in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 9d34049d7c583ccd426393b116c0da47 and manufactured by INSTRUMENTATION LABORATORY CO.. The authorized representative in Taiwan is Werfen Taiwan Limited.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
9d34049d7c583ccd426393b116c0da47
Registration Details
Taiwan FDA Registration: 9d34049d7c583ccd426393b116c0da47
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Cimosir Rivaroxaban correction liquid and quality control liquid
TW: ๅธŒๆ‘ฉ่ฅฟ็ˆพRivaroxabanๆ กๆญฃๆถฒๅŠๅ“็ฎกๆถฒ
Risk Class 2

Registration Details

9d34049d7c583ccd426393b116c0da47

DHA05603111404

Company Information

United States

Product Details

This product is suitable for calibration and quality control when measuring Rivaroxaban in the Liquid Anti-Xa test of ACL TOP Family.

A Clinical chemistry and clinical toxicology

A.1150 calibration;; A.1660 Quality control materials (analytical and non-analytical)

import

Dates and Status

May 16, 2018

May 16, 2028